Junxia Yao

704 total citations
46 papers, 499 citations indexed

About

Junxia Yao is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Junxia Yao has authored 46 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Immunology and 12 papers in Oncology. Recurrent topics in Junxia Yao's work include Acute Myeloid Leukemia Research (8 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (5 papers). Junxia Yao is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Immunotherapy and Immune Responses (6 papers) and Immune Cell Function and Interaction (5 papers). Junxia Yao collaborates with scholars based in China, Germany and United States. Junxia Yao's co-authors include Shiang Huang, Yanli He, Jine Zheng, Xingbing Wang, Jing Yang, Zhongping Liu, Xiaoqing Li, Jun Liu, Wen Du and Michael Schmitt and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Oncogene.

In The Last Decade

Junxia Yao

43 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junxia Yao China 13 216 158 149 144 63 46 499
Ryosei Nishimura Japan 11 279 1.3× 170 1.1× 162 1.1× 252 1.8× 47 0.7× 37 625
V. Granger United Kingdom 11 162 0.8× 195 1.2× 136 0.9× 67 0.5× 34 0.5× 15 467
Ana Serra‐Caetano Portugal 10 236 1.1× 64 0.4× 144 1.0× 51 0.4× 33 0.5× 13 478
Fabio Guolo Italy 10 91 0.4× 112 0.7× 78 0.5× 127 0.9× 28 0.4× 46 306
Zonghong Shao China 13 229 1.1× 272 1.7× 146 1.0× 98 0.7× 39 0.6× 80 540
Miho Nara Japan 12 138 0.6× 144 0.9× 276 1.9× 113 0.8× 193 3.1× 31 613
Odit Gutwein Israel 8 157 0.7× 121 0.8× 90 0.6× 193 1.3× 24 0.4× 17 415
Lindsay Hladnik United States 8 135 0.6× 278 1.8× 129 0.9× 217 1.5× 21 0.3× 12 482
Brandt L. Esplin United States 9 416 1.9× 196 1.2× 166 1.1× 97 0.7× 21 0.3× 12 621
Margaret M. Showel United States 10 112 0.5× 340 2.2× 168 1.1× 126 0.9× 23 0.4× 29 476

Countries citing papers authored by Junxia Yao

Since Specialization
Citations

This map shows the geographic impact of Junxia Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junxia Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junxia Yao more than expected).

Fields of papers citing papers by Junxia Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junxia Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junxia Yao. The network helps show where Junxia Yao may publish in the future.

Co-authorship network of co-authors of Junxia Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Junxia Yao. A scholar is included among the top collaborators of Junxia Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junxia Yao. Junxia Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Pengcheng, et al.. (2025). Research progress on circular RNA in the regulation of drug resistance in genitourinary cancers. Cellular and Molecular Life Sciences. 82(1). 158–158.
2.
3.
Wang, Weixia, Yingyi Zhang, Jican Liu, et al.. (2023). Comparison of the prognostic value of stromal tumor-infiltrating lymphocytes and CD3 + T cells between schistosomal and non-schistosomal colorectal cancer. World Journal of Surgical Oncology. 21(1). 31–31. 2 indexed citations
4.
Lu, Cong, Dong Hu, Jine Zheng, et al.. (2022). A Six‐Gene Risk Model Based on the Immune Score Reveals Prognosis in Intermediate‐Risk Acute Myeloid Leukemia. BioMed Research International. 2022(1). 4010786–4010786. 1 indexed citations
6.
Ma, Li, Fanli Hua, Zhihui Min, et al.. (2022). Exosomal circCARM1 from spheroids reprograms cell metabolism by regulating PFKFB2 in breast cancer. Oncogene. 41(14). 2012–2025. 32 indexed citations
7.
Wei, Luyao, Wantao Wang, Junxia Yao, et al.. (2022). PACT promotes the metastasis of basal-like breast cancer through Rac1 SUMOylation and activation. Oncogene. 41(37). 4282–4294. 6 indexed citations
9.
Han, Yan, Yingying Wu, Zhaodong Zhong, et al.. (2021). Case Report: Asymmetric Bone Marrow Involvement in Patients With Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation. Frontiers in Oncology. 11. 626018–626018. 1 indexed citations
10.
Lu, Cong, Jiang Zhu, Xiangjun Chen, et al.. (2020). Risk Stratification in Acute Myeloid Leukemia Using CXCR Gene Signatures: A Bioinformatics Analysis. Frontiers in Oncology. 10. 584766–584766. 15 indexed citations
11.
Wang, Weixia, Kui Lu, Limei Wang, et al.. (2020). Comparison of non-schistosomal colorectal cancer and schistosomal colorectal cancer. World Journal of Surgical Oncology. 18(1). 149–149. 11 indexed citations
12.
Lu, Kui, et al.. (2020). PALB2 as a potential prognostic biomarker for colorectal cancer. Computational Biology and Chemistry. 87. 107289–107289. 5 indexed citations
13.
Lu, Jinchang, Chunling Du, Junxia Yao, et al.. (2017). C/EBPα Suppresses Lung Adenocarcinoma Cell Invasion and Migration by Inhibiting β-Catenin. Cellular Physiology and Biochemistry. 42(5). 1779–1788. 14 indexed citations
14.
Du, Wen, Juan Li, Wei Liu, et al.. (2015). Interleukin-3 receptor α chain (CD123) is preferentially expressed in immature T-ALL and may not associate with outcomes of chemotherapy. Tumor Biology. 37(3). 3817–3821. 8 indexed citations
15.
Casalegno‐Garduño, Rosaely, Anita Schmitt, Junxia Yao, et al.. (2009). Multimer technologies for detection and adoptive transfer of antigen-specific T cells. Cancer Immunology Immunotherapy. 59(2). 195–202. 32 indexed citations
16.
Schmitt, Anita, et al.. (2009). Cytomegalovirus vaccination of leukemia and lymphoma patients after allogeneic stem cell transplantation — Validation of a peptide vaccine. Journal of Immunological Methods. 343(2). 140–147. 6 indexed citations
17.
Yao, Junxia, Markus Wiesneth, Georg Härter, et al.. (2008). Multimer Staining of Cytomegalovirus Phosphoprotein 65–Specific T Cells for Diagnosis and Therapeutic Purposes: A Comparative Study. Clinical Infectious Diseases. 46(10). e96–e105. 39 indexed citations
18.
Zheng, Jine, Xingbing Wang, Yu Hu, et al.. (2007). A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China. Cytometry Part B Clinical Cytometry. 74B(1). 25–29. 40 indexed citations
19.
Liu, Li, Junxia Yao, Qian Ding, & Shiang Huang. (2006). CD4+CD25high regulatory cells in peripheral blood of NSCLC patients. Journal of Huazhong University of Science and Technology [Medical Sciences]. 26(5). 548–551. 12 indexed citations
20.
Wang, Xingbing, Jine Zheng, Jun Liu, et al.. (2005). Increased population of CD4+CD25high regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients. European Journal Of Haematology. 75(6). 468–476. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026